Ameriprise’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.1M | Buy |
193,649
+84,513
| +77% | +$27.6M | 0.02% | 748 |
|
|
2025
Q1 | $29.5M | Sell |
109,136
-18,937
| -15% | -$5.11M | 0.01% | 1098 |
|
|
2024
Q4 | $30.1M | Sell |
128,073
-9,765
| -7% | -$2.3M | 0.01% | 1109 |
|
|
2024
Q3 | $37.9M | Sell |
137,838
-100,482
| -42% | -$27.6M | 0.01% | 978 |
|
|
2024
Q2 | $57.9M | Buy |
238,320
+43,595
| +22% | +$10.6M | 0.02% | 732 |
|
|
2024
Q1 | $29.1M | Sell |
194,725
-182,934
| -48% | -$27.3M | 0.01% | 1072 |
|
|
2023
Q4 | $72.3M | Sell |
377,659
-328,541
| -47% | -$62.9M | 0.02% | 628 |
|
|
2023
Q3 | $125M | Buy |
706,200
+80,862
| +13% | +$14.3M | 0.04% | 413 |
|
|
2023
Q2 | $119M | Buy |
625,338
+422,168
| +208% | +$80.2M | 0.04% | 454 |
|
|
2023
Q1 | $40.7M | Buy |
203,170
+155,795
| +329% | +$31.2M | 0.01% | 851 |
|
|
2022
Q4 | $11.3M | Buy |
47,375
+37,804
| +395% | +$8.98M | ﹤0.01% | 1641 |
|
|
2022
Q3 | $1.91M | Sell |
9,571
-914
| -9% | -$183K | ﹤0.01% | 2802 |
|
|
2022
Q2 | $1.54M | Sell |
10,485
-2,167
| -17% | -$317K | ﹤0.01% | 2924 |
|
|
2022
Q1 | $2.02M | Buy |
12,652
+115
| +0.9% | +$18.4K | ﹤0.01% | 2906 |
|
|
2021
Q4 | $2.07M | Buy |
12,537
+1,823
| +17% | +$301K | ﹤0.01% | 2938 |
|
|
2021
Q3 | $2.02M | Sell |
10,714
-45,941
| -81% | -$8.68M | ﹤0.01% | 2870 |
|
|
2021
Q2 | $9.61M | Buy |
56,655
+7,274
| +15% | +$1.23M | ﹤0.01% | 1971 |
|
|
2021
Q1 | $7.03M | Buy |
49,381
+7,636
| +18% | +$1.09M | ﹤0.01% | 2157 |
|
|
2020
Q4 | $5.43M | Buy |
41,745
+14,176
| +51% | +$1.84M | ﹤0.01% | 2212 |
|
|
2020
Q3 | $4.02M | Buy |
27,569
+2,514
| +10% | +$366K | ﹤0.01% | 2240 |
|
|
2020
Q2 | $3.71M | Buy |
25,055
+11,308
| +82% | +$1.67M | ﹤0.01% | 2272 |
|
|
2020
Q1 | $1.5M | Buy |
13,747
+781
| +6% | +$85K | ﹤0.01% | 2628 |
|
|
2019
Q4 | $1.49M | Buy |
12,966
+46
| +0.4% | +$5.29K | ﹤0.01% | 2879 |
|
|
2019
Q3 | $1.04M | Buy |
12,920
+789
| +7% | +$63.5K | ﹤0.01% | 3003 |
|
|
2019
Q2 | $880K | Sell |
12,131
-18,006
| -60% | -$1.31M | ﹤0.01% | 3110 |
|
|
2019
Q1 | $2.82M | Buy |
30,137
+274
| +0.9% | +$25.6K | ﹤0.01% | 2569 |
|
|
2018
Q4 | $2.17M | Sell |
29,863
-27,186
| -48% | -$1.98M | ﹤0.01% | 2612 |
|
|
2018
Q3 | $4.99M | Sell |
57,049
-47,219
| -45% | -$4.13M | ﹤0.01% | 2337 |
|
|
2018
Q2 | $10.3M | Buy |
104,268
+79,311
| +318% | +$7.81M | ﹤0.01% | 1715 |
|
|
2018
Q1 | $2.97M | Buy |
24,957
+22,357
| +860% | +$2.66M | ﹤0.01% | 2508 |
|
|
2017
Q4 | $331K | Buy |
2,600
+428
| +20% | +$54.5K | ﹤0.01% | 3325 |
|
|
2017
Q3 | $255K | Buy |
+2,172
| New | +$255K | ﹤0.01% | 3434 |
|
|
2016
Q4 | – | Sell |
-21,571
| Closed | -$1.46M | – | 3866 |
|
|
2016
Q3 | $1.46M | Buy |
+21,571
| New | +$1.46M | ﹤0.01% | 2726 |
|
|
2016
Q1 | – | Sell |
-16,345
| Closed | -$1.54M | – | 3733 |
|
|
2015
Q4 | $1.54M | Sell |
16,345
-1,790
| -10% | -$169K | ﹤0.01% | 2737 |
|
|
2015
Q3 | $1.46M | Buy |
18,135
+13,107
| +261% | +$1.05M | ﹤0.01% | 2778 |
|
|
2015
Q2 | $603K | Buy |
5,028
+2,054
| +69% | +$246K | ﹤0.01% | 3321 |
|
|
2015
Q1 | $310K | Sell |
2,974
-6,820
| -70% | -$711K | ﹤0.01% | 3406 |
|
|
2014
Q4 | $951K | Sell |
9,794
-428,783
| -98% | -$41.6M | ﹤0.01% | 2897 |
|
|
2014
Q3 | $34.3M | Buy |
438,577
+354,342
| +421% | +$27.7M | 0.02% | 664 |
|
|
2014
Q2 | $5.32M | Sell |
84,235
-135,276
| -62% | -$8.55M | ﹤0.01% | 2040 |
|
|
2014
Q1 | $14.7M | Sell |
219,511
-97,187
| -31% | -$6.53M | 0.01% | 1217 |
|
|
2013
Q4 | $20.4M | Sell |
316,698
-249,349
| -44% | -$16M | 0.01% | 981 |
|
|
2013
Q3 | $36.2M | Sell |
566,047
-96,578
| -15% | -$6.18M | 0.02% | 669 |
|
|
2013
Q2 | $20.5M | Buy |
+662,625
| New | +$20.5M | 0.01% | 959 |
|